These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28743748

  • 1. Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.
    Xie S, Manuguri S, Proietti G, Romson J, Fu Y, Inge AK, Wu B, Zhang Y, Häll D, Ramström O, Yan M.
    Proc Natl Acad Sci U S A; 2017 Aug 08; 114(32):8464-8469. PubMed ID: 28743748
    [Abstract] [Full Text] [Related]

  • 2. Research on antibacterial and antifungal agents. XI. New antibacterial quinolones related to pirfloxacin.
    Massa S, Corelli F, Mai A, Artico M, Panico S, Simonetti N.
    Farmaco; 1989 Sep 08; 44(9):779-93. PubMed ID: 2604833
    [Abstract] [Full Text] [Related]

  • 3. [Synthesis and antibacterial activity of ciprofloxacin derivatives].
    Ye FQ, Ding YM, Chen L, Ye S, Chen ZX.
    Yao Xue Xue Bao; 2005 Feb 08; 40(2):132-5. PubMed ID: 15875668
    [Abstract] [Full Text] [Related]

  • 4. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
    Gao Y, Na LX, Xu Z, Zhang S, Wang AP, Lü K, Guo HY, Liu ML.
    Chem Biodivers; 2018 Oct 08; 15(10):e1800261. PubMed ID: 29987907
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents.
    Azéma J, Guidetti B, Korolyov A, Kiss R, Roques C, Constant P, Daffé M, Malet-Martino M.
    Eur J Med Chem; 2011 Dec 08; 46(12):6025-38. PubMed ID: 22036229
    [Abstract] [Full Text] [Related]

  • 6. [Studies on quinolone antibacterials. I. Synthesis and antibacterial activity of 7-(2-aminoethoxy)-, 7-(2-aminoethylthio)-, and 7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo qui noline -3-carboxylic acids and their derivatives].
    Yoshida T, Yamamoto Y, Yagi N, Yasuda S, Katoh H, Itoh Y.
    Yakugaku Zasshi; 1990 Apr 08; 110(4):258-67. PubMed ID: 2198342
    [Abstract] [Full Text] [Related]

  • 7. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
    Hu AX, Wang YT, You TB.
    Yao Xue Xue Bao; 2007 Aug 08; 42(8):854-7. PubMed ID: 17944234
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.
    Wang R, Yin X, Zhang Y, Yan W.
    Eur J Med Chem; 2018 Aug 05; 156():580-586. PubMed ID: 30025351
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
    Kant R, Singh V, Nath G, Awasthi SK, Agarwal A.
    Eur J Med Chem; 2016 Nov 29; 124():218-228. PubMed ID: 27592391
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V, Belakhov V, Hainrichson M, Yaron S, Baasov T.
    J Med Chem; 2009 Apr 23; 52(8):2243-54. PubMed ID: 19301822
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space.
    Ross AG, Benton BM, Chin D, De Pascale G, Fuller J, Leeds JA, Reck F, Richie DL, Vo J, LaMarche MJ.
    Bioorg Med Chem Lett; 2015 Sep 01; 25(17):3468-75. PubMed ID: 26189081
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and antibacterial activity of 4,5,6,7-tetrahydro-thieno[3,2-c]pyridine quinolones.
    Srivastava BK, Solanki M, Mishra B, Soni R, Jayadev S, Valani D, Jain M, Patel PR.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):1924-9. PubMed ID: 17276057
    [Abstract] [Full Text] [Related]

  • 13. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
    Vila J, Sánchez-Céspedes J, Sierra JM, Piqueras M, Nicolás E, Freixas J, Giralt E.
    Int J Antimicrob Agents; 2006 Jul 01; 28(1):19-24. PubMed ID: 16781123
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
    Xu Z, Zhang S, Feng LS, Li XN, Huang GC, Chai Y, Lv ZS, Guo HY, Liu ML.
    Molecules; 2017 Jul 13; 22(7):. PubMed ID: 28703766
    [Abstract] [Full Text] [Related]

  • 15. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE, Gedawy EM.
    Eur J Med Chem; 2018 Apr 25; 150():403-418. PubMed ID: 29547830
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
    Zhang Y, Li G, Liu M, You X, Feng L, Lv K, Cao J, Guo H.
    Bioorg Med Chem Lett; 2011 Feb 01; 21(3):928-31. PubMed ID: 21232952
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT, Blondeau JM.
    J Chemother; 2005 Oct 01; 17(5):484-92. PubMed ID: 16323436
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.
    Xiao ZP, Wang XD, Wang PF, Zhou Y, Zhang JW, Zhang L, Zhou J, Zhou SS, Ouyang H, Lin XY, Mustapa M, Reyinbaike A, Zhu HL.
    Eur J Med Chem; 2014 Jun 10; 80():92-100. PubMed ID: 24769347
    [Abstract] [Full Text] [Related]

  • 19. [Synthesis and antibacterial activity of 7-(4-acylamino-thiocarbamoyl-1-piperazinyl) fluoroquinolone analogues in vitro].
    Qu LB, Tian MC, Cheng SX, Chen RF.
    Yao Xue Xue Bao; 2003 Apr 10; 38(4):264-7. PubMed ID: 12889124
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J.
    Antimicrob Agents Chemother; 2001 Nov 10; 45(11):3113-21. PubMed ID: 11600365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.